SCHEMBL19255693

SCHEMBL19255693

Nc1nc(-c2n[nH]c3c(F)cc(F)cc23)ncc1F

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.31
MAPK14 Q16539 1/20 0.31
SGK1 O00141 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19255178 0.86 MAPK1 (0.31)
SCHEMBL19255555 0.82
SCHEMBL19255752 0.81 CHEK1 (0.36) EGFRSGK1
SCHEMBL9977698 0.81 PIK3CG (0.35)
SCHEMBL19255585 0.76 REN (0.34)
SCHEMBL17518517 0.75 AR (0.46)
SCHEMBL786095 0.75 GPR84 (0.40) EGFRMAPK14SGK1
SCHEMBL19250804 0.73 NOS3 (0.33)
SCHEMBL19250682 0.73 SGK1 (0.33) SGK1
SCHEMBL19886542 0.73 TNKS (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017133670-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed